Resveratrol Dosage: What Human Trials Used and How Much Is Too Much?

There is no single evidence-based resveratrol dosage that has been proven best for everyone. Human trials have used doses ranging from tens of milligrams to several grams per day, but those studies tested different populations, formulations and endpoints. A dose used in a pharmacokinetic study is not automatically a recommended daily dose, and the highest dose ever studied is not the most effective dose.

For most people comparing supplements, the more useful question is: what dose was used for the outcome I care about, and how strong was the result?

Resveratrol dosage at a glance

Dose range	How it appears in human research	What it means
~25–100 mg	Pharmacokinetic and lower-dose experimental studies	Useful for understanding absorption; not proof of clinical benefit.
~150–500 mg/day	Common range in metabolic, cognitive and recent musculoskeletal trials	Frequently studied, but results remain outcome- and population-specific.
~1,000–1,500 mg/day	Used in some metabolic, enzyme-interaction and liver studies	Higher exposure does not guarantee greater benefit; tolerability and interactions matter more.
2,500–5,000 mg/day	Mostly pharmacokinetic or high-dose safety research	GI adverse effects become more important. These are not sensible default supplement targets.

What doses were used in major human trials?

Clinical studies illustrate why “the resveratrol dose” is the wrong concept.

Study context	Approximate dose	What happened
Early human pharmacokinetics	25 mg single oral dose	Absorption was substantial, but unchanged circulating resveratrol remained low because of rapid metabolism.
Metabolic study in men with obesity	150 mg/day for about 30 days	Reported favorable metabolic and mitochondrial signals.
Otherwise healthy men with obesity	1,500 mg/day for 4 weeks	Did not reproduce a broad metabolic benefit despite a ten-fold larger daily dose than the earlier positive trial.
Drug-metabolism study in healthy volunteers	1,000 mg/day for 4 weeks	Altered activity of multiple CYP enzymes, highlighting interaction potential.
2025 knee-OA/frailty trial	500 mg/day for 16 weeks	Reported improvements in several symptoms/function measures and plasma SIRT1.
2026 cognition/microbiome trial	500 mg/day for 12 weeks	Largely null across microbiome, metabolome, adiposity and inflammatory/oxidative outcomes.
High-dose safety/pharmacokinetic research	Up to gram-level and multi-gram dosing	Useful for defining exposure and tolerability; GI adverse effects become more prominent at the upper end.

The most important lesson is visible in the table: a larger dose did not reliably produce a larger clinical effect.

Is 500 mg of resveratrol a lot?

Five hundred milligrams per day is a commonly seen supplement dose and has been used in several human trials. That makes it a research-relevant dose. It does not make it a universally optimal dose.

At 500 mg/day, the expected exposure still depends on the formulation and the person taking it. A 2025 randomized crossover pharmacokinetic study showed that two oral formulations could produce markedly different peak and total exposure even when both contained resveratrol. Read Resveratrol Bioavailability for why this matters.

Is 1,000 mg of resveratrol safe?

One gram per day has been used in controlled human research, including a study that examined effects on drug-metabolizing enzymes. Short-term use at this dose has been tolerated by many participants, but that does not mean one gram is risk-free or appropriate for everyone.

At higher intakes, gastrointestinal adverse effects become more common, and the interaction question becomes more important. If you take prescription medicines, dose selection should not be separated from a medication review. See Resveratrol Drug Interactions.

What is the maximum resveratrol dose?

There is no universally accepted “maximum daily dose” established for routine long-term supplementation. Human studies have administered several grams per day, but these upper-range exposures are primarily useful for pharmacokinetic, cancer-prevention or safety research. They should not be converted into consumer targets.

A high-dose trial showing that participants completed treatment is not the same as evidence that chronic multi-gram supplementation is useful, optimal or free of risk.

Why higher doses are not necessarily better

Three features of resveratrol make a simple dose-escalation strategy unreliable.

1. Rapid metabolism

Resveratrol is extensively converted into glucuronide and sulfate metabolites. Increasing an oral dose changes exposure, but parent resveratrol does not simply rise in a perfectly proportional way across tissues.

2. Biological effects can be nonlinear

Many signaling compounds show dose-dependent or context-dependent effects. A pathway response that is favorable at one exposure does not have to become more favorable as the dose rises.

3. Trials using larger doses are not consistently more positive

The contrast between the 150 mg/day Timmers metabolic study and the later 1,500 mg/day Poulsen trial is a useful example. The lower-dose study generated positive metabolic signals; the ten-times-higher dose did not reproduce broad benefits in another group of men with obesity. Population and design differences matter, but the result still breaks the assumption that “more resveratrol equals more effect.”

Resveratrol dosage by goal

No disease-specific dose has regulatory approval as a resveratrol treatment. The table below therefore describes research ranges, not prescriptions.

Goal being researched	Typical research territory	Evidence note
Metabolic health / insulin sensitivity	~150 mg to 1,500 mg/day in notable trials	Mixed results; high-level evidence does not identify one optimal dose.
Vascular function	Lower to moderate doses used across acute/chronic studies	Some promising surrogate outcomes such as FMD; no hard cardiovascular-outcome dose established.
Cognition	Moderate-dose regimens, often hundreds of mg/day	Mixed findings; no proven cognitive-optimization dose.
Osteoarthritis	500 mg/day in recent positive trials; different low-dose formulation in ARTHROL	Evidence conflicts across trials and formulations.
Longevity	No human longevity dose exists	No dose has been shown to extend human lifespan.

When should you take resveratrol?

Human efficacy trials use different schedules, including once-daily and divided dosing. There is not strong clinical evidence that one clock time—morning versus night—universally improves outcomes.

The practical priorities are consistency, tolerability and avoiding medication conflicts. Claims that everyone should take resveratrol with a high-fat meal are also stronger than the current evidence permits. Food can affect pharmacokinetics, but the direction and clinical significance depend on the formulation and study conditions.

Should resveratrol be taken with food?

If taking it with food improves gastrointestinal tolerance, that can be a practical reason to do so. But “take it with fat to boost absorption” should not be treated as a universal rule. Resveratrol pharmacokinetics are dominated by rapid metabolism, and formulation-specific data are more informative than a generic fat-solubility slogan.

Do trans-resveratrol and resveratrol use the same dosage?

Most modern supplements emphasize trans-resveratrol, the form most commonly discussed in the research literature. When comparing labels, check whether the stated milligram amount refers to total plant extract, total resveratrol or actual trans-resveratrol. A 500 mg Japanese knotweed extract is not necessarily 500 mg of trans-resveratrol.

Who should not self-escalate the dose?

• People taking anticoagulants or antiplatelet medicines.
• People taking medicines metabolized through CYP pathways that resveratrol may affect.
• People preparing for surgery.
• People with significant liver or kidney disease unless their clinician has reviewed supplementation.
• Pregnant or breastfeeding people because adequate safety data are lacking.
• Anyone developing persistent diarrhea, abdominal pain, nausea or other adverse effects.

A practical evidence-based dosing framework

1. Start with the intended outcome. Find the human trials most relevant to that population and endpoint.
2. Look at the formulation, not just milligrams. Exposure can differ materially between products.
3. Do not chase the highest published dose. High-dose studies often answer safety or PK questions, not optimization questions.
4. Review medications first. Interaction risk can matter more than whether the label says 250 or 500 mg.
5. Reassess whether the expected benefit is actually supported. A dose cannot rescue an endpoint that has not demonstrated convincing human efficacy.

Bottom line

The clinical literature does not support a single “best resveratrol dosage.” Human trials frequently sit in the 150–500 mg/day range, while some studies use one gram or more, but outcomes do not improve in a simple dose-dependent fashion. Multi-gram doses belong to research history, not default supplement advice.

Before choosing a dose, read Resveratrol Side Effects, Drug Interactions and Bioavailability. For the broader evidence, see our 2026 Resveratrol guide and the Resveratrol Data Center.